Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors
Bernadett Szabados, Yasmin Abu‐Ghanem, Michael Grant, Julia Choy, Axel Bex, Thomas Powles
Topics & Concepts
MedicineAtezolizumabIpilimumabNivolumabInternal medicineCancerDiseaseOncologyGenitourinary systemImmunotherapyCOVID-19 and healthcare impactsCancer Immunotherapy and BiomarkersCOVID-19 Clinical Research Studies